CERO Insider Trading Activity and SEC Form 4 Filings
CERO insider trading summary
No open-market insider purchases or sales of Cero Therapeutics Holdings, Inc. (CERO) have been reported on SEC Form 4 in the past 12 months.
Latest CERO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 13, 2024 | Mitchell William Kossar | 10% Owner | Sell | $180K (2,998,908 @ $0.06) |
| Dec 13, 2024 | YK Bioventures Opportunities Fund I, L.P. | 10% Owner | Sell | $180K (2,998,908 @ $0.06) |
| Dec 13, 2024 | Gary Kahing Yeung | 10% Owner | Sell | $180K (2,998,908 @ $0.06) |
| Dec 13, 2024 | YK Bioventures Opportunities GP I, LLC | Insider | Sell | $180K (2,998,908 @ $0.06) |
| Dec 12, 2024 | YK Bioventures Opportunities Fund I, L.P. | 10% Owner | Sell | $113K (1,614,541 @ $0.07) |
| Dec 12, 2024 | Mitchell William Kossar | 10% Owner | Sell | $113K (1,614,541 @ $0.07) |
| Dec 12, 2024 | YK Bioventures Opportunities GP I, LLC | Insider | Sell | $113K (1,614,541 @ $0.07) |
| Dec 12, 2024 | Gary Kahing Yeung | 10% Owner | Sell | $113K (1,614,541 @ $0.07) |
| Dec 11, 2024 | YK Bioventures Opportunities Fund I, L.P. | 10% Owner | Sell | $108K (1,343,801 @ $0.08) |
| Dec 11, 2024 | Gary Kahing Yeung | 10% Owner | Sell | $108K (1,343,801 @ $0.08) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.